435 related articles for article (PubMed ID: 31817238)
21. Disruption of sphingolipid metabolism augments ceramide-induced autophagy in preeclampsia.
Melland-Smith M; Ermini L; Chauvin S; Craig-Barnes H; Tagliaferro A; Todros T; Post M; Caniggia I
Autophagy; 2015 Apr; 11(4):653-69. PubMed ID: 25853898
[TBL] [Abstract][Full Text] [Related]
22. Human meconium contains significant amounts of alkaline sphingomyelinase, neutral ceramidase, and sphingolipid metabolites.
Duan RD; Cheng Y; Jönsson BA; Ohlsson L; Herbst A; Hellström-Westas L; Nilsson A
Pediatr Res; 2007 Jan; 61(1):61-6. PubMed ID: 17211142
[TBL] [Abstract][Full Text] [Related]
23. The Dark Side of Sphingolipids: Searching for Potential Cardiovascular Biomarkers.
Di Pietro P; Izzo C; Abate AC; Iesu P; Rusciano MR; Venturini E; Visco V; Sommella E; Ciccarelli M; Carrizzo A; Vecchione C
Biomolecules; 2023 Jan; 13(1):. PubMed ID: 36671552
[TBL] [Abstract][Full Text] [Related]
24. Activation of sphingolipid turnover and chronic generation of ceramide and sphingosine in liver during aging.
Lightle SA; Oakley JI; Nikolova-Karakashian MN
Mech Ageing Dev; 2000 Dec; 120(1-3):111-25. PubMed ID: 11087909
[TBL] [Abstract][Full Text] [Related]
25. Metabolism of ceramide-containing endocytotic vesicles in human diploid fibroblasts.
Sutrina SL; Chen WW
J Biol Chem; 1982 Mar; 257(6):3039-44. PubMed ID: 7061463
[TBL] [Abstract][Full Text] [Related]
26. Degradation of glycosphingolipids in oyster: ceramide glycanase and ceramidase in the hepatopancreas of oyster, Crassostrea virginica.
Pavlova NV; Li SC; Li YT
Glycoconj J; 2018 Feb; 35(1):77-86. PubMed ID: 29039121
[TBL] [Abstract][Full Text] [Related]
27. Alkaline ceramidase family: The first two decades.
Xu R; Antwi Boasiako P; Mao C
Cell Signal; 2021 Feb; 78():109860. PubMed ID: 33271224
[TBL] [Abstract][Full Text] [Related]
28. Gene cloning of a neutral ceramidase from the sphingolipid metabolic pathway based on transcriptome analysis of Amorphophallus muelleri.
Zhong L; Liu E; Yang C; Diao Y; Harijati N; Liu J; Hu Z; Jin S
PLoS One; 2018; 13(3):e0194863. PubMed ID: 29590184
[TBL] [Abstract][Full Text] [Related]
29. Measurement of ceramide and sphingolipid metabolism in tumors: potential modulation of chemotherapy.
Modrak DE
Methods Mol Med; 2005; 111():183-94. PubMed ID: 15911980
[TBL] [Abstract][Full Text] [Related]
30. Neutral ceramidase: Advances in mechanisms, cell regulation, and roles in cancer.
Coant N; Hannun YA
Adv Biol Regul; 2019 Jan; 71():141-146. PubMed ID: 30389354
[TBL] [Abstract][Full Text] [Related]
31. Novel fluorescent ceramide derivatives for probing ceramidase substrate specificity.
Bhabak KP; Proksch D; Redmer S; Arenz C
Bioorg Med Chem; 2012 Oct; 20(20):6154-61. PubMed ID: 22989909
[TBL] [Abstract][Full Text] [Related]
32. Aerobic training in rats increases skeletal muscle sphingomyelinase and serine palmitoyltransferase activity, while decreasing ceramidase activity.
Błachnio-Zabielska A; Zabielski P; Baranowski M; Gorski J
Lipids; 2011 Mar; 46(3):229-38. PubMed ID: 21181285
[TBL] [Abstract][Full Text] [Related]
33. Purification and characterization of human intestinal neutral ceramidase.
Ohlsson L; Palmberg C; Duan RD; Olsson M; Bergman T; Nilsson A
Biochimie; 2007 Aug; 89(8):950-60. PubMed ID: 17475390
[TBL] [Abstract][Full Text] [Related]
34. Chemotherapy selection pressure alters sphingolipid composition and mitochondrial bioenergetics in resistant HL-60 cells.
Kao LP; Morad SAF; Davis TS; MacDougall MR; Kassai M; Abdelmageed N; Fox TE; Kester M; Loughran TP; Abad JL; Fabrias G; Tan SF; Feith DJ; Claxton DF; Spiegel S; Fisher-Wellman KH; Cabot MC
J Lipid Res; 2019 Sep; 60(9):1590-1602. PubMed ID: 31363040
[TBL] [Abstract][Full Text] [Related]
35. New fluorogenic probes for neutral and alkaline ceramidases.
Casasampere M; Bielsa N; Riba D; Bassas L; Xu R; Mao C; Fabriàs G; Abad JL; Delgado A; Casas J
J Lipid Res; 2019 Jun; 60(6):1174-1181. PubMed ID: 30926626
[TBL] [Abstract][Full Text] [Related]
36. Ceramidases in hematological malignancies: senseless or neglected target?
Fabrias G; Bedia C; Casas J; Abad JL; Delgado A
Anticancer Agents Med Chem; 2011 Nov; 11(9):830-43. PubMed ID: 21707488
[TBL] [Abstract][Full Text] [Related]
37. Drug targeting of sphingolipid metabolism: sphingomyelinases and ceramidases.
Canals D; Perry DM; Jenkins RW; Hannun YA
Br J Pharmacol; 2011 Jun; 163(4):694-712. PubMed ID: 21615386
[TBL] [Abstract][Full Text] [Related]
38. Deficiency of the alkaline ceramidase ACER3 manifests in early childhood by progressive leukodystrophy.
Edvardson S; Yi JK; Jalas C; Xu R; Webb BD; Snider J; Fedick A; Kleinman E; Treff NR; Mao C; Elpeleg O
J Med Genet; 2016 Jun; 53(6):389-96. PubMed ID: 26792856
[TBL] [Abstract][Full Text] [Related]
39. Altered adipose and plasma sphingolipid metabolism in obesity: a potential mechanism for cardiovascular and metabolic risk.
Samad F; Hester KD; Yang G; Hannun YA; Bielawski J
Diabetes; 2006 Sep; 55(9):2579-87. PubMed ID: 16936207
[TBL] [Abstract][Full Text] [Related]
40. Increase in sphingolipid catabolic enzyme activity during aging.
Sacket SJ; Chung HY; Okajima F; Im DS
Acta Pharmacol Sin; 2009 Oct; 30(10):1454-61. PubMed ID: 19749786
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
